These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34033889)

  • 21. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
    Hong JS; Yoon EJ; Lee H; Jeong SH; Lee K
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7216-7223. PubMed ID: 27671068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection or colonization in a Chinese teaching hospital.
    Zhang D; Cui K; Wang T; Shan Y; Dong H; Feng W; Ma C; Dong Y
    J Infect Dev Ctries; 2018 Aug; 12(8):642-648. PubMed ID: 31958327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya.
    Pitout JD; Revathi G; Chow BL; Kabera B; Kariuki S; Nordmann P; Poirel L
    Clin Microbiol Infect; 2008 Aug; 14(8):755-9. PubMed ID: 18727799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, Molecular Characteristics, and Virulence Factors of Carbapenem-Resistant
    Park Y; Koo SH
    Infect Drug Resist; 2022; 15():141-151. PubMed ID: 35058697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outbreak of IMP-producing carbapenem-resistant Enterobacter gergoviae among kidney transplant recipients.
    Freire MP; de Oliveira Garcia D; Cury AP; Spadão F; Di Gioia TS; Francisco GR; Bueno MF; Tomaz M; de Paula FJ; de Faro LB; Piovesan AC; Rossi F; Levin AS; David Neto E; Nahas WC; Pierrotti LC
    J Antimicrob Chemother; 2016 Sep; 71(9):2577-85. PubMed ID: 27197663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study.
    Coppry M; Jeanne-Leroyer C; Noize P; Dumartin C; Boyer A; Bertrand X; Dubois V; Rogues AM
    J Antimicrob Chemother; 2019 Feb; 74(2):503-510. PubMed ID: 30376042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal Microbiota Disruption and Risk of Colonization With Carbapenem-resistant Pseudomonas aeruginosa in Intensive Care Unit Patients.
    Pettigrew MM; Gent JF; Kong Y; Halpin AL; Pineles L; Harris AD; Johnson JK
    Clin Infect Dis; 2019 Aug; 69(4):604-613. PubMed ID: 30383203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries.
    Castanheira M; Deshpande LM; Costello A; Davies TA; Jones RN
    J Antimicrob Chemother; 2014 Jul; 69(7):1804-14. PubMed ID: 24603963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial Susceptibility Profiles To Predict the Presence of Carbapenemase Genes among Carbapenem-Resistant Pseudomonas aeruginosa Isolates.
    Vallabhaneni S; Huang JY; Grass JE; Bhatnagar A; Sabour S; Lutgring JD; Campbell D; Karlsson M; Kallen AJ; Nazarian E; Snavely EA; Morris S; Wang C; Lee R; Koag M; Lewis R; Garcia B; ; Brown AC; Walters MS
    J Clin Microbiol; 2021 May; 59(6):. PubMed ID: 33762362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals.
    Telling K; Laht M; Brauer A; Remm M; Kisand V; Maimets M; Tenson T; Lutsar I
    BMC Infect Dis; 2018 Oct; 18(1):513. PubMed ID: 30309321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Bundle of Measures to Control an Outbreak of Pseudomonas aeruginosa Associated With P-Trap Contamination.
    Gbaguidi-Haore H; Varin A; Cholley P; Thouverez M; Hocquet D; Bertrand X
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):164-169. PubMed ID: 29417923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region: emergence of VIM-2-producing isolates.
    Pitout JD; Chow BL; Gregson DB; Laupland KB; Elsayed S; Church DL
    J Clin Microbiol; 2007 Feb; 45(2):294-8. PubMed ID: 17122002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study.
    Reyes J; Komarow L; Chen L; Ge L; Hanson BM; Cober E; Herc E; Alenazi T; Kaye KS; Garcia-Diaz J; Li L; Kanj SS; Liu Z; Oñate JM; Salata RA; Marimuthu K; Gao H; Zong Z; Valderrama-Beltrán SL; Yu Y; Tambyah P; Weston G; Salcedo S; Abbo LM; Xie Q; Ordoñez K; Wang M; Stryjewski ME; Munita JM; Paterson DL; Evans S; Hill C; Baum K; Bonomo RA; Kreiswirth BN; Villegas MV; Patel R; Arias CA; Chambers HF; Fowler VG; Doi Y; van Duin D; Satlin MJ;
    Lancet Microbe; 2023 Mar; 4(3):e159-e170. PubMed ID: 36774938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbapenem-resistant Enterobacteriaceae among kidney transplant recipients - insights on the risk of acquisition and CRE infection.
    Freire MP; Carvalho LB; Reusing JO; Spadão F; Lopes MIBF; Nahas WC; David-Neto E; Pierrotti LC
    Infect Dis (Lond); 2021 Jun; 53(6):430-439. PubMed ID: 33612056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain.
    Tu Y; Wang D; Zhu Y; Li J; Jiang Y; Wu W; Li X; Zhou H
    Microbiol Spectr; 2022 Feb; 10(1):e0186921. PubMed ID: 35019766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of a suspected IMP-type carbapenemase-producing
    Gual-de-Torrella A; López-Causape C; Alejo-Cancho I; Rojo-Molinero E; Sanchez-García G; Cortés-Lara S; Rodríguez Moral MB; Berdonces-Gonzalez P; Lopez de Goikoetxea MJ; Oliver A
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1801-1808. PubMed ID: 37138359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region.
    Zowawi HM; Syrmis MW; Kidd TJ; Balkhy HH; Walsh TR; Al Johani SM; Al Jindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Sidjabat HE; Baz O; Trembizki E; Whiley DM; Paterson DL
    J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.